Real-time enrollment status for this hodgkin lymphoma clinical trial
Current Status
Active, Not Recruiting
Checked: April 17, 2026 at 5:37 AM UTC
| NCT Number | NCT06504394 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Hodgkin Lymphoma |
| Phase | Clinical Trial |
| Target Enrollment | 60 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Merck Sharp & Dohme LLC |
| Last Updated on CT.gov | February 9, 2026 (Feb 9, 2026) |
As of April 17, 2026: Clinical trial NCT06504394 is currently active_not_recruiting participants. This clinical trial study for hodgkin lymphoma is not currently accepting new participants at 4 locations across the United States. The study is sponsored by Merck Sharp & Dohme LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06504394 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06504394 was last updated Feb 9, 2026 (February 9, 2026). HelloStudys verifies this status automatically.